首頁 > 市場調查報告書 > 製藥

麻醉

市場調查報告書

商品編碼

1812406

氯胺酮診所市場：依治療方式、臨床指徵、給藥途徑、病患年齡層、治療類型、轉診管道、經營模式和地區分類

Ketamine Clinic Market, By Therapy Modality, By Clinical Indication, By Route of Administration, By Patient Age Group, By Care Type, By Referral Channel, By Business Model, By Geography

出版日期: 2025年08月29日 | 出版商:

Coherent Market Insights | 英文 168 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

氯胺酮診所市場規模預計在 2025 年達到 14.4 億美元，預計到 2032 年將達到 30.3 億美元，2025 年至 2032 年的複合年成長率為 11.2%。

報告範圍		報告詳細資訊
基準年	2024	2025年的市場規模	14.4億美元
效能數據	2020年至2024年	預測期	2020年至2024年
預測期：2025-2032年複合年成長率：	11.20%	2032年的價值預測	30.3億美元

全球氯胺酮診所市場是心理健康和疼痛管理領域一個快速發展的細分市場，其特點是擁有專門的醫療機構，將氯胺酮用於各種治療用途。這些診所主要提供氯胺酮輸注療法，用於治療難治性憂鬱症、慢性疼痛、創傷後壓力症候群 (PTSD)、焦慮症以及其他傳統療法已證明療效不佳的神經精神疾病。氯胺酮作為 N-甲基-D-天冬胺酸 (NMDA) 受體拮抗劑，其獨特的作用機制逐漸被認可，能夠快速發揮抗憂鬱症和鎮痛作用，因此氯胺酮市場正經歷著巨大的發展勢頭。

氯胺酮專科診所的成立是為了滿足日益成長的替代治療模式需求，尤其是針對那些對傳統抗憂鬱症或疼痛管理療法無效的患者。該市場涵蓋多種服務模式，包括獨立氯胺酮診所、醫院內氯胺酮治療中心以及綜合精神衛生機構。隨著美國食品藥物管理局 (FDA)核准esketamine(Spravato)鼻噴霧，氯胺酮治療的監管格局已發生顯著變化，這進一步使氯胺酮治療合法化，並透過提高臨床應用率和患者接受度來推動市場擴張。

市場動態

全球氯胺酮臨床市場受到幾個關鍵促進因素的支撐，包括全球難治性憂鬱症和精神疾病的盛行率不斷上升，約有 30% 的憂鬱症患者對傳統抗憂鬱症沒有反應。醫療保健專業人員和患者越來越意識到氯胺酮的速效抗憂鬱症特性，這種特性通常在數小時而不是數週內就會有所改善，這極大地推動了市場採用。此外，醫學界對氯胺酮療法的接受度不斷提高，大量臨床研究證明其對一系列神經精神疾病有效，這進一步推動了市場成長。然而，氯胺酮療法面臨重大限制，包括治療費用高昂，通常每次治療費用從 400 美元到 800 美元不等，通常不在保險範圍內，這使得許多患者無法接受。

氯胺酮仿單標示外用藥的監管複雜性以及用藥過程中需要專門的醫療監督，給診所的運作帶來了挑戰。此外，氯胺酮濫用風險、解離效應以及需要密切病患監測等安全隱患也限制了市場發展。儘管存在這些挑戰，但仍存在向醫療資源匱乏地區擴張、制定標準化治療通訊協定以及將氯胺酮療法與數位健康平台相結合以加強病患監測等方面的巨大機會。此外，將氯胺酮與心理療法或其他藥物療法結合的聯合治療的潛力也為未來發展提供了新的途徑。持續研究新型氯胺酮製劑及給藥方法，可望進一步擴大潛在市場並改善治療效果。

本次調查的主要特點

本報告對全球氯胺酮診所市場進行了詳細分析，展示了預測期（2025-2032 年）的市場規模（十億美元）和年複合成長率（CAGR%），以 2024 年為基準年。
它還揭示了各個領域的潛在商機，並解釋了該市場有吸引力的投資提案矩陣。
它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景以及主要企業採用的競爭策略的重要見解。
它根據公司亮點、產品系列、關鍵亮點、業績和策略等參數，概述了全球氯胺酮診所市場的主要企業。
本報告的見解將使負責人和公司經營團隊能夠就未來的產品發布、類型升級、市場擴張和行銷策略做出明智的決策。
全球氯胺酮診所市場報告涉及該行業的各個相關人員，包括投資者、供應商、產品製造商、經銷商、新進業者和金融分析師。
相關人員可以透過用於分析全球氯胺酮診所市場的各種策略矩陣更輕鬆地做出決策。

難治性單相憂鬱症
重度憂鬱症伴隨急性自殺想法/行為
雙極性憂鬱症
創傷後壓力症候群
焦慮症
強迫症
物質使用疾患（例如 AUD）
神經病變疼痛（例如 CRPS、糖尿病神經病變）
慢性肌肉骨骼疼痛（例如腰痛/骨關節炎）
纖維肌痛
偏頭痛/頭痛症
癌症相關疼痛/安寧療護疼痛

6. 全球氯胺酮診所市場（依給藥途徑），2020-2032 年

口服
腸外
鼻腔

7. 2020-2032 年全球氯胺酮診所市場（依病患年齡層）

青少年（13-17歲）
成人（18-64歲）
老年人（65歲以上）

8. 2020 年至 2032 年全球氯胺酮診所市場（依治療類型）

僅藥物治療
氯胺酮輔助心理治療

9. 2025-2032 年全球氯胺酮診所市場（按轉診管道）

直接面對消費者或自我推薦
醫生轉診（精神科/基層醫療）
付款人/案件管理推薦

第 10 章。全球氯胺酮診所市場，依經營模式，2020-2032 年

獨立經營私人診所
專利權經營診所
醫院附設診所
研究與臨床試驗中心
其他（擴大麻醉科及心理治療）

第 11 章。 2020 年至 2032 年按地區分類的全球氯胺酮診所市場

北美洲
拉丁美洲
歐洲
亞太地區
中東
非洲

第12章競爭格局

Mindbloom Inc.
Mindful Health Solutions
Field Trip Health
Nushama Psychedelic Wellness Center
Klarisana
Revitalist Lifestyle and Wellness
Ketamine Clinics Los Angeles
Actify Neurotherapies
Ember Health
Bloom Mental Health
Joyous
HealingMaps Ketamine Network
Klarity Clinic
The Stella Center
NY Ketamine Infusions
MindPeace Clinics

第 13 章分析師建議

機會
分析師觀點
Coherent Opportunity Map

第14章參考文獻與調查方法

參考
調查方法
關於出版商

簡介目錄

Product Code: CMI8503

Ketamine Clinic Market is estimated to be valued at USD 1.44 Bn in 2025 and is expected to reach USD 3.03 Bn by 2032, growing at a compound annual growth rate (CAGR) of 11.2% from 2025 to 2032.

Report Coverage		Report Details
Base Year:	2024	Market Size in 2025:	USD 1.44 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2020 To 2024
Forecast Period 2025 to 2032 CAGR:	11.20%	2032 Value Projection:	USD 3.03 Bn

The global ketamine clinic market represents a rapidly evolving segment within the mental health and pain management healthcare landscape, characterized by specialized medical facilities that administer ketamine-based treatments for various therapeutic applications. These clinics primarily focus on providing ketamine infusion therapy for treatment-resistant depression, chronic pain conditions, Post-Traumatic Stress Disorder (PTSD), anxiety disorders, and other neuropsychiatric conditions where traditional treatments have proven inadequate. The market has gained significant momentum due to the growing recognition of ketamine's unique mechanism of action as an N-methyl-D-aspartate (NMDA) receptor antagonist, which offers rapid-onset antidepressant effects and analgesic properties.

The establishment of dedicated ketamine clinics has emerged as a response to the increasing demand for alternative treatment modalities, particularly for patients who have not responded to conventional antidepressants or pain management therapies. This market encompasses various service delivery models, including standalone ketamine clinics, hospital-based ketamine treatment centers, and integrated mental health facilities. The regulatory landscape surrounding ketamine administration has evolved significantly, with the U.S. FDA approval of esketamine (Spravato) nasal spray further legitimizing ketamine-based treatments and driving market expansion through increased clinical adoption and patient acceptance.

Market Dynamics

The global ketamine clinic market is propelled by several key drivers, including the rising prevalence of treatment-resistant depression and mental health disorders worldwide, with approximately 30% of depression patients not responding to traditional antidepressants, creating substantial demand for alternative therapeutic interventions. The growing awareness among healthcare professionals and patients about ketamine's rapid-acting antidepressant properties, often showing improvement within hours rather than weeks, significantly drives market adoption. Additionally, the increasing acceptance of ketamine therapy by medical communities, supported by extensive clinical research demonstrating efficacy in various neuropsychiatric conditions, further accelerates market growth. However, the market faces notable restraints, including high treatment costs that limit accessibility for many patients, as ketamine therapy sessions typically range from USD 400-800 per treatment and are often not covered by insurance providers.

Regulatory complexities surrounding off-label ketamine use and the requirement for specialized medical supervision during administration create operational challenges for clinic establishments. Safety concerns related to ketamine's potential for abuse, dissociative effects, and the need for careful patient monitoring also pose market limitations. Despite these challenges, significant opportunities exist in the market expansion into underserved geographical regions, development of standardized treatment protocols, and integration of ketamine therapy with digital health platforms for enhanced patient monitoring. The potential for combination therapies incorporating ketamine with psychotherapy or other medications presents additional growth avenues, while ongoing research into novel ketamine formulations and delivery methods could further expand the addressable market and improve treatment outcomes.

Key Features of the Study

This report provides in-depth analysis of the global ketamine clinic market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global ketamine clinic market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Mindbloom Inc., Mindful Health Solutions, Field Trip Health, Nushama Psychedelic Wellness Center, Klarisana, Revitalist Lifestyle and Wellness, Ketamine Clinics Los Angeles, Actify Neurotherapies, Ember Health, Bloom Mental Health, Joyous, HealingMaps Ketamine Network, Klarity Clinic, The Stella Center, NY Ketamine Infusions, and MindPeace Clinics
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global ketamine clinic market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global ketamine clinic market

Market Segmentation

Therapy Modality Insights (Revenue, USD Bn, 2020 - 2032)
- On-Site/In-Clinic Therapy
- Online Ketamine Therapy Consultation Services/Telehealth Therapy
Clinical Indication Insights (Revenue, USD Bn, 2020 - 2032)
- Treatment-resistant unipolar depression
- Major depressive disorder with acute suicidal ideation/behavior
- Bipolar depression
- Post-traumatic stress disorder
- Anxiety disorders
- Obsessive-compulsive disorder
- Substance use disorders (e.g., AUD)
- Neuropathic pain (e.g., CRPS, diabetic neuropathy)
- Chronic musculoskeletal pain (e.g., low back/osteoarthritis)
- Fibromyalgia
- Migraine/headache disorders
- Cancer-related/palliative pain
Route of Administration Insights (Revenue, USD Bn, 2020 - 2032)
- Oral
- Parenteral
- Nasal
Patient Age Group Insights (Revenue, USD Bn, 2020 - 2032)
- Adolescents (13-17)
- Adults (18-64)
- Geriatric (65+)
Care Type Insights (Revenue, USD Bn, 2020 - 2032)
- Medication-only
- Ketamine-assisted psychotherapy
Referral Channel Insights (Revenue, USD Bn, 2020 - 2032)
- Direct-to-consumer or self-referred
- Physician-referred (psychiatry/primary care)
- Payer/case-management referred
Business Model Insights (Revenue, USD Bn, 2020 - 2032)
- Independently owned private clinic
- Franchise-Owned clinics
- Hospital affiliated clinics
- Research and Clinical Trial Centers
- Others (Anesthesiology/psychology practice extension)
Regional Insights (Revenue, USD Bn, 2020 - 2032)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
- Mindbloom Inc.
- Mindful Health Solutions
- Field Trip Health
- Nushama Psychedelic Wellness Center
- Klarisana
- Revitalist Lifestyle and Wellness
- Ketamine Clinics Los Angeles
- Actify Neurotherapies
- Ember Health
- Bloom Mental Health
- Joyous
- HealingMaps Ketamine Network
- Klarity Clinic
- The Stella Center
- NY Ketamine Infusions
- MindPeace Clinics

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Global Ketamine Clinic Market, By Therapy Modality
- Global Ketamine Clinic Market, By Clinical Indication
- Global Ketamine Clinic Market, By Route of Administration
- Global Ketamine Clinic Market, By Patient Age Group
- Global Ketamine Clinic Market, By Care Type
- Global Ketamine Clinic Market, By Referral Channel
- Global Ketamine Clinic Market, By Business Model
- Global Ketamine Clinic Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
Driver
Restraint
Opportunity
Impact Analysis
Key Developments
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario
Industry Trends

4. Global Ketamine Clinic Market, By Therapy Modality, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
On-Site/In-Clinic Therapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Online Ketamine Therapy Consultation Services/Telehealth Therapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

5. Global Ketamine Clinic Market, By Clinical Indication, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Treatment-resistant unipolar depression
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Major depressive disorder with acute suicidal ideation/behavior
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Bipolar depression
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Post-traumatic stress disorder
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Anxiety disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Obsessive-compulsive disorder
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Substance use disorders (e.g., AUD)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Neuropathic pain (e.g., CRPS, diabetic neuropathy)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Chronic musculoskeletal pain (e.g., low back/osteoarthritis)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Fibromyalgia
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Migraine/headache disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Cancer-related/palliative pain
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Ketamine Clinic Market, By Route of Administration, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Parenteral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Nasal
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Ketamine Clinic Market, By Patient Age Group, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Adolescents (13-17)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Adults (18-64)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Geriatric (65+)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Ketamine Clinic Market, By Care Type, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Medication-only
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Ketamine-assisted psychotherapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

9. Global Ketamine Clinic Market, By Referral Channel, 2025-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Direct-to-consumer or self-referred
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Physician-referred (psychiatry/primary care)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Payer/case-management referred
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

10. Global Ketamine Clinic Market, By Business Model, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Independently owned private clinic
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Franchise-Owned clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Hospital affiliated clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Research and Clinical Trial Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Others (Anesthesiology/psychology practice extension)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

11. Global Ketamine Clinic Market, By Region, 2020 - 2032, Value (USD Bn)

Introduction
- Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Bn)
- Regional Trends
North America
- Introduction
- Market Size and Forecast, By Therapy Modality, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Clinical Indication, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Patient Age Group, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Care Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Referral Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Business Model, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, By Therapy Modality, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Clinical Indication, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Patient Age Group, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Care Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Referral Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Business Model, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, By Therapy Modality, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Clinical Indication, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Patient Age Group, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Care Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Referral Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Business Model, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, By Therapy Modality, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Clinical Indication, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Patient Age Group, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Care Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Referral Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Business Model, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, By Therapy Modality, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Clinical Indication, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Patient Age Group, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Care Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Referral Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Business Model, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, By Therapy Modality, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Clinical Indication, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Patient Age Group, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Care Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Referral Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Business Model, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Bn)
  - South Africa
  - North Africa
  - Central Africa

12. Competitive Landscape

Mindbloom Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Mindful Health Solutions
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Field Trip Health
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Nushama Psychedelic Wellness Center
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Klarisana
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Revitalist Lifestyle and Wellness
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Ketamine Clinics Los Angeles
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Actify Neurotherapies
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Ember Health
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Bloom Mental Health
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Joyous
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
HealingMaps Ketamine Network
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Klarity Clinic
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
The Stella Center
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
NY Ketamine Infusions
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
MindPeace Clinics
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies